Neuronoff Inc., a Cleveland startup developing minimally invasive neuromodulation systems, has been awarded or recommended ...

Chronic pain is a global health challenge, with current treatment options often limited by side effects, addiction risk, and diminished effectiveness over time. In a new study, Yale researchers ...

The global electric wheelchairs market size was valued at USD 4.35 billion in 2024 and is projected to reach from USD 4.87 ...

Storm started suffering seizures when he was 12 weeks old, and now he has to take 31 pills a day to manage his life-threatening condition.

Guillain-Barre Syndrome (GBS) is a rare neurological disorder characterized by sudden numbness, breathing and swallowing problems, pain, muscle weakness.

In a report released today, Brooks O’Neil from Lake Street maintained a Buy rating on Alphatec Holdings (ATEC – Research Report), with a price ...

Clinically Meaningful Benefit Observed at Both ATH434 Doses Studied –– Achieved Statistical Significance with Up to 48% Slowing of Clinical ...

Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for ...

REGENXBIO Inc. today announced data from its RGX-121 (clemidsogene lanparvovec) program for the treatment of mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, will be shared at ...

As U.S. markets navigate a period of uncertainty with the Federal Reserve maintaining interest rates and investors closely watching major tech earnings, attention turns to identifying promising growth ...

The oversubscribed Series B will boost the clinical development of two RNAi therapies for epilepsy and Huntington’s disease ...

SMPL Jaipur Rajasthan [India] January 30 ManglamPlus Medicity Jaipur multi-specialty hospital is poised to attract medical ...